Karla Resendiz, PharmD, BCPPS, BCCCP
Areas of expertise: Pediatric critical care
About Karla Resendiz
Titles
Clinical Pharmacy Specialist, Pediatric Critical Care
Certifications
Board Certified Critical Care Pharmacist (BCCCP)
Board Certified Pediatric Pharmacy Specialist (BCPPS)
Leadership and Memberships
Memberships in Professional Organizations
American Society of Health-System Pharmacists (ASHP)
Pediatric Cardiac Intensive Care Society (PCICS)
Pediatric Pharmacy Association (PPA); Research Committee
Society of Critical Care Medicine (SCCM); Item Writing Committee
Research Interests
Sedation Nutrition Support Cardiopulmonary resuscitation
Education & training
Graduate Degree
Doctor of Pharmacy – University of Texas at Austin, Austin, TX
Residency
Pharmacy Practice (PGY 1) – Children’s National Medical Center, Washington, DC
Pediatric Specialty (PGY 2) – Medical University of South Carolina, Charleston, SC
Publications
Publications
2020
O’Neil ER; Schmees LR; Resendiz K et al. Inhaled Tranexamic Acid As a Novel Treatment for Pulmonary Hemorrhage in Critically Ill Pediatric Patients. Crit Care Explor 2020; 2(1):e0075
Resendiz K, Humlicek TJ, Moffett BS. Drugs. In Mery CM (ed), Texas Children’s Hospital Handbook of Congenital Heart Disease (pp.522-534). Houston, TX: Texas Children’s Hospital, 2020.
2019
Moffett BS, Resendiz K, Morris J et al. Population Pharmacokinetics of Vancomycin in the Pediatric Cardiac Surgical Population. J Pediatr Pharmacol Ther. 2019 Mar-Apr; 24(2): 107–116
Resendiz K, Achuff B. Opioid and benzodiazepine bolus use in a pediatric intensive care unit during a city-wide catastrophe. Crit Care Med 2019; 47(1): 665.
2018
Achuff B, Jain P, Resendiz K, et al. Objective sedation in a Pediatric Cardiac Intensive Care Unit decreases narcotic exposure. Crit Care Med 2018; 46(1): 630
Jain P, Achuff BJ, Resendiz K, et al. Do Children with Down syndrome really need higher sedation and analgesia after cardiac surgery? Crit Care Med 2018; 46(1): 98
2017
Resendiz K, Elhoff J, Achuff B, et al. Evaluation of vasopressin effects on ST-segment variability in critically ill pediatric patients. Presented at the Pediatric Cardiac Intensive Care Society’s 13th Annual International Meeting. Washington, DC. December, 2017